Logo image of AVDL

AVADEL PHARMACEUTICALS (AVDL) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:AVDL - IE00BDGMC594 - Common Stock

21.37 USD
-0.05 (-0.23%)
Last: 12/16/2025, 4:20:04 PM
21.37 USD
0 (0%)
After Hours: 12/16/2025, 4:20:04 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
AVDL revenue by date.AVDL revenue by date.
27.963M169.117M
504.79%
279.84M
65.47%
366.25M
30.88%
462.49M
26.28%
491.77M
6.33%
527.69M
7.30%
468.18M
-11.28%
N/A
EBITDA
YoY % growth
AVDL ebitda by date.AVDL ebitda by date.
-93.723M
-10.54%
-136.083M
-45.20%
-39.718M
70.81%
24.786M
162.40%
87.924M
254.73%
123.88M
40.89%
159.29M
28.58%
183.3M
15.07%
N/AN/A
EBIT
YoY % growth
AVDL ebit by date.AVDL ebit by date.
-95.216M
-11.23%
-137.849M
-44.78%
-42.399M
69.24%
23.733M
155.98%
103.18M
334.75%
146.57M
42.05%
189.85M
29.53%
223.18M
17.56%
182.58M
-18.19%
232.56M
27.37%
Operating Margin
AVDL operating margin by date.AVDL operating margin by date.
N/A-492.97%-25.07%8.48%28.17%31.69%38.61%42.29%39.00%N/A
EPS
YoY % growth
AVDL eps by date.AVDL eps by date.
-2.25
-70.45%
-2.01
10.67%
-0.52
74.13%
0.20
138.39%
0.83
313.31%
1.26
52.94%
1.63
29.48%
2.07
26.64%
1.21
-41.34%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.09
289.43%
0.14
371.99%
0.19
87.00%
0.210.21
120.76%
0.10
-25.00%
0.14
-23.63%
0.19
-8.07%
0.24
17.07%
Revenue
Q2Q % growth
80.251M
59.20%
81.667M
55.52%
91.327M
34.05%
95.858M
23.74%
97.181M
21.10%
83.13M
1.79%
90.984M
-0.38%
100.37M
4.71%
107.92M
11.05%
EBITDA
Q2Q % growth
13.311M
2,260.88%
17.34M
896.88%
21.726M
101.60%
22.644M
597.12%
21.93M
64.75%
15.606M
-10.00%
21.114M
-2.82%
28.866M
27.48%
35.7M
62.79%
EBIT
Q2Q % growth
11.117M
437.19%
15.32M
610.50%
22.04M
148.09%
24.587M
425.10%
28.424M
155.68%
14.484M
-5.46%
19.992M
-9.29%
27.846M
13.25%
34.68M
22.01%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.00
100.00%
0.07-0.07-100.00%
Q2 2025
Q2Q % growth
0.10
171.43%
0.030.07258.07%
Q1 2025
Q2Q % growth
-0.05
83.33%
-0.070.0231.20%
Q4 2024
Q2Q % growth
-0.05
82.76%
-0.04-0.01-20.15%
Q3 2024
Q2Q % growth
-0.03
92.68%
-0.060.0346.72%
Q2 2024
Q2Q % growth
-0.14
83.13%
-0.160.0211.79%
Q1 2024
Q2Q % growth
-0.30
37.50%
-0.21-0.09-41.55%
Q4 2023
Q2Q % growth
-0.29
36.96%
-0.26-0.03-9.63%
Q3 2023
Q2Q % growth
-0.41
-24.24%
-0.38-0.03-7.98%
Q2 2023
Q2Q % growth
-0.83
17.82%
-0.39-0.44-111.75%
Q1 2023
Q2Q % growth
-0.48
-6.67%
-0.38-0.10-24.86%
Q4 2022
Q2Q % growth
-0.46
-21.05%
-0.28-0.18-66.41%
Q3 2022
Q2Q % growth
-0.33
13.16%
-0.26-0.07-27.71%
Q2 2022
Q2Q % growth
-1.01
-206.06%
-0.42-0.59-141.71%
Q1 2022
Q2Q % growth
-0.45
-95.65%
-0.44-0.01-2.01%
Q4 2021
Q2Q % growth
-0.38
-100.00%
-0.420.0410.01%
Q3 2021
Q2Q % growth
-0.38
-90.00%
-0.390.013.23%
Q2 2021
Q2Q % growth
-0.33
-120.00%
-0.32-0.01-2.89%
Q1 2021
Q2Q % growth
-0.23
-1,050.00%
-0.320.0929.04%
Q4 2020
Q2Q % growth
-0.19
-171.43%
-0.280.0931.29%
Q3 2020
Q2Q % growth
-0.20
16.67%
-0.260.0621.96%
Q2 2020
Q2Q % growth
-0.15
34.78%
-0.10-0.05-52.79%
Q1 2020
Q2Q % growth
-0.02
94.29%
-0.240.2291.76%
Q4 2019
Q2Q % growth
-0.07 -0.250.1871.99%
Q3 2019
Q2Q % growth
-0.24 -0.280.0412.85%
Q2 2019
Q2Q % growth
-0.23 -0.300.0722.24%
Q1 2019
Q2Q % growth
-0.35 -0.500.1529.97%
AVDL Yearly EPS VS EstimatesAVDL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
77.467M
54.86%
75.045M2.422M3.23%
Q2 2025
Q2Q % growth
68.129M
64.15%
62.728M5.401M8.61%
Q1 2025
Q2Q % growth
52.511M
93.21%
51.724M787K1.52%
Q4 2024
Q2Q % growth
50.41M
159.14%
51.034M-624K-1.22%
Q3 2024
Q2Q % growth
50.025M
613.22%
49.579M446K0.90%
Q2 2024
Q2Q % growth
41.504M
2,674.33%
38.285M3.219M8.41%
Q1 2024
Q2Q % growth
27.178M 26.416M762K2.88%
Q4 2023
Q2Q % growth
19.453M 18.574M879K4.73%
Q3 2023
Q2Q % growth
7.014M 5.19M1.824M35.14%
Q2 2023
Q2Q % growth
1.496M 643.763K852.237K132.38%
Q2 2021
Q2Q % growth

-100.00%
%
Q1 2021
Q2Q % growth

-100.00%
%
Q4 2020
Q2Q % growth

-100.00%
%
Q3 2020
Q2Q % growth

-100.00%
%
Q2 2020
Q2Q % growth
10.091M
-42.51%
7.516M2.575M34.26%
Q1 2020
Q2Q % growth
12.243M
-25.52%
10.353M1.89M18.26%
Q4 2019
Q2Q % growth
10.995M 9.316M1.679M18.02%
Q3 2019
Q2Q % growth
14.229M 10.455M3.774M36.10%
Q2 2019
Q2Q % growth
17.554M 10.71M6.844M63.90%
Q1 2019
Q2Q % growth
16.437M 14.153M2.284M16.14%
AVDL Yearly Revenue VS EstimatesAVDL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS4.63% -20.73% -12.53% -17.47%
Revenue0.81% 0.21% 0.77% 0.55%